The first Japanese site in an AGITG trial opens for INTEGRATE II
The first AGITG trial site in Japan has opened for the INTEGRATE II study in gastro-oesophageal cancer. National Cancer... Read More
How the GI Cancer Institute’s research is developed
The GI Cancer Institute’s research and clinical trials are developed through a robust, scientific process. The studies we... Read More
Our Clinical Trials: Colorectal Cancer
March is Colorectal Cancer Awareness Month, and the GI Cancer Institute is joining people and organisations worldwide to... Read More
Breaking new ground in exercise and colorectal cancer treatment
Exercise can have significant benefits for cancer treatment and recovery, and new research is discovering the full extent... Read More
First patient enrolled in RENO
The RENO study has activated its first site and the first patient has been enrolled in the study.... Read More
Colorectal Cancer does not discriminate – one patient’s story
“GI cancer does not discriminate. I was only 49 when I was diagnosed.” – Paula Kotowicz, bowel cancer... Read More
Our Research Priorities: What is key to the future of research?
During 2017 our Board of Directors and management created a revised Strategic Plan for the organisation and its... Read More
What is Cholangiocarcinoma? #WorldCCADay 2019
Biliary tract or bile duct cancer – cholangiocarcinoma – is a rare cancer affecting the gall bladder and bile ducts.... Read More
Gastro-intestinal surgeons receive Australia Day honours
Excellence in gastro-intestinal (GI) cancer research and treatment has been recognised on the Australia Day 2019 Honours List,... Read More
Bowel cancer screening key to reducing deaths in Australia
The Australian Government has announced that it is investing $10 million to encourage Australians to participate in the... Read More
Interview: Clinical Research Fellow Dr David Lau
Dr David Lau is three months into his fellowship at Royal Marsden Hospital, London. “It has been incredible,” he... Read More
How to care for your skin during colorectal cancer treatment
Chemotherapy treatments for colorectal cancer can have side effects that could affect your skin. The treatments cetuximab and... Read More
Cancer drugs made available on PBS for gastro-intestinal cancer patients
The Department of Health has announced on Saturday 1 December that five new cancer listings have been made... Read More
John Logan Foundation closes after eight years of giving hope to patients
The John Logan Foundation will close in 2018 after eight years of financially supporting Australians with gastro-intestinal cancers.... Read More
Gutsy Challenge: The Overland Track
The Gutsy Challenge went to Tasmania this year, with two teams taking on the wilderness. The first team, led by Professor Steve Ackland, took on a series of walks through the wilderness, facing snow and storms as they hiked over 60km.The second Gutsy Challenge Team took on Tasmania’s iconic Overland Track,... Read More
CONTROL NETs accrues final patients
The CONTROL NETs trial in neuroendocrine tumours (NETs) has finished patient accrual and is now in follow-up. NETs are... Read More
The history of AGITG pancreatic cancer research
In the early 2000s, there was only one drug available for pancreatic cancer, gemcitabine. This was not a... Read More
Congratulations to the 2018 AGITG award winners
The 20th Annual AGITG Annual Scientific Meeting was held from 30 October-2 November. At the Annual Scientific Meeting... Read More
Best of Posters and Fast Forward at the Annual Scientific Meeting
The AGITG Annual Scientific Meeting accepts abstracts and posters for submission to the Best of Posters and Fast... Read More
Immunotherapy for pancreatic cancer awarded Best New Concept
New research into the potential benefit of immunotherapy for pancreatic cancer patients has been recognised at the AGITG’s... Read More